To include your compound in the COVID-19 Resource Center, submit it here.

Trio of IPOs price: Arvinas, Sutro, Urovant

Arvinas Inc. (NASDAQ:ARVN), Sutro Biopharma Inc. (NASDAQ:STRO) and Urovant Sciences Ltd. (NASDAQ:UROV) each priced IPOs late Wednesday, raising a total of $345 million.

On Thursday, Arvinas gained $0.05 to $16, and Sutro was up $0.20 to $15.20. Urovant was off $2.35 (17%) to

Read the full 423 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers